Athanase Innovation AB (ATIN) — Cash Flow Reinvestment Rate
Athanase Innovation AB (ATIN) has a Cash Flow Reinvestment Rate of 0.99x as of June 2024, reinvesting Skr6.49 Million (capex Skr6.49 Million ) from operating cash flow of Skr6.54 Million. Check Athanase Innovation AB (ATIN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Athanase Innovation AB Cash Flow Reinvestment Rate (2018–2021)
Historical reinvestment intensity for Athanase Innovation AB across 4 annual periods. Explore Athanase Innovation AB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Athanase Innovation AB (2018–2021)
Year-by-year capital reinvestment analysis for Athanase Innovation AB. For live market cap and broader valuation context, see ATIN company net worth.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 9.19x | Skr212.40 Million | Skr23.10 Million | Skr65.00K | — |
| 2020 | 0.00x | Skr0.00 | Skr22.34 Million | Skr0.00 | — |
| 2019 | 0.00x | Skr0.00 | Skr28.38 Million | Skr0.00 | — |
| 2018 | 0.00x | Skr0.00 | Skr15.05 Million | Skr0.00 | — |